Cumberland Pharmaceuticals Inc. (CPIX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cumberland Pharmaceuticals Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -20.99x | -5.14x | -4.08x | -5.88x | -19.84x | -13.39x |
| P/B Ratio | 2.39x | 1.46x | 0.86x | 0.90x | 1.63x | 0.95x |
| P/S Ratio | 1.34x | 0.88x | 0.65x | 0.78x | 1.93x | 1.19x |
| Profitability | ||||||
| Gross Margin | 85.0% | 82.6% | 84.7% | 78.3% | 75.5% | 76.9% |
| Operating Margin | -6.3% | -17.0% | -24.2% | -13.6% | -21.3% | -17.0% |
| Net Margin | -6.4% | -17.1% | -15.9% | -13.3% | -9.7% | -8.9% |
| EBITDA Margin | 5.6% | 0.5% | 6.3% | 0.8% | -2.4% | -4.2% |
| Liquidity | ||||||
| Current Ratio | 1.01x | 1.15x | 1.28x | 1.60x | 2.37x | 1.95x |
| Quick Ratio | 0.84x | 1.03x | 1.11x | 1.26x | 1.93x | 1.53x |
| Leverage | ||||||
| Debt/Equity | 0.41x | 0.90x | 0.62x | 0.58x | 0.38x | 0.41x |
YoY = year-over-year change. Source: FMP..